How new initiative of APRaD will contribute to transparency of Ukrainian pharma market

The Ukraine Association of Pharmaceutical Research and Development (APRaD), uniting the largest world leading pharmaceutical companies active in the research and development of new medicines with a presence in Ukraine, will disclose the information on transfers of value to healthcare professionals and organizations.

The intention of the pharmaceutical industry to be more transparent to a wider audience is not a new idea and currently managed by the relevant Disclosure Code, which was developed and accepted by the European Federation of Pharmaceutical Industries and Associations (EFPIA) in 2013. Also, other examples of such high principles of cooperation between pharmaceutical companies and healthcare professionals fixed at the legislation level have been known in the world practice (Sunshine Act, USA).

APRaD, being an affiliate member of EFPIA, actively promotes and encourages ethical business principles and practices among its members and the pharmaceutical industry in general in Ukraine. In 2014, the APRaD updated its Code of Pharmaceutical Marketing Practices by adding article 14 “On disclosure of transfers of value to healthcare professionals and organizations», which fully corresponds to the international practice.